Essa Pharma (EPIX) Income Statement (2019 - 2025)
Income Statement report data from Dec 31, 2019 to Jun 30, 2025 for Essa Pharma (EPIX).
Reported currency: USD
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||
Research And Development | -530.00K | 3.48M (-36.38%) | 5.47M (+30.55%) | 4.19M (-23.26%) | 5.46M (-11.65%) | 6.18M (+14.87%) | 5.38M (+2.87%) | 5.23M (-16.59%) | 6.27M (+39.96%) | 4.48M (-16.10%) | 5.34M (+22.76%) | 4.35M (-31.92%) | 6.39M (-16.47%) | 7.65M (+27.08%) | 6.02M (-3.99%) | 6.27M (+0.64%) | 6.23M (-14.31%) | 7.27M (+61.92%) | 4.49M (+100.45%) | 2.24M (-17.04%) | 2.70M (-41.56%) | 4.62M (+78.38%) | 2.59M |
Selling General And Administrative | 5.43M (+39.23%) | 3.90M (-7.36%) | 4.21M (+19.94%) | 3.51M (+10.73%) | 3.17M (-26.62%) | 4.32M (+94.59%) | 2.22M (+15.63%) | 1.92M (-27.27%) | 2.64M (-29.22%) | 3.73M (+48.02%) | 2.52M (-9.03%) | 2.77M (-4.48%) | 2.90M (-24.08%) | 3.82M (+24.84%) | 3.06M (+4.08%) | 2.94M (-5.77%) | 3.12M (-32.47%) | 4.62M (+109.05%) | 2.21M (+0.45%) | 2.20M (+1.38%) | 2.17M (-55.35%) | 4.86M (+127.10%) | 2.14M |
Operating Expenses | 4.90M (-33.60%) | 7.38M (-23.76%) | 9.68M (+25.88%) | 7.69M (-11.00%) | 8.64M (-17.64%) | 10M (+38.21%) | 7.59M (+6.15%) | 7.15M (-19.75%) | 8.91M (+8.53%) | 8.21M (+4.32%) | 7.87M (+10.53%) | 7.12M (-23.36%) | 9.29M (-19.01%) | 11M (+26.32%) | 9.08M (-1.52%) | 9.22M (-1.60%) | 9.37M (-21.13%) | 12M (+77.31%) | 6.70M (+47.25%) | 4.55M (-10.26%) | 5.07M (-47.02%) | 9.57M (+93.72%) | 4.94M |
Operating Income | |||||||||||||||||||||||
Operating Income | -4.90M (-33.60%) | -7.38M (-23.76%) | -9.68M (+25.88%) | -7.69M (-11.00%) | -8.64M (-17.64%) | -10.49M (+38.21%) | -7.59M (+6.15%) | -7.15M (-19.75%) | -8.91M (+8.53%) | -8.21M (+4.32%) | -7.87M (+10.53%) | -7.12M (-23.36%) | -9.29M (-19.01%) | -11.47M (+26.32%) | -9.08M (-1.52%) | -9.22M (-1.60%) | -9.37M (-21.13%) | -11.88M (+77.31%) | -6.70M (+47.25%) | -4.55M (-10.26%) | -5.07M (-47.02%) | -9.57M (+93.72%) | -4.94M |
EBITDA | -4.90M (-33.60%) | -7.38M (-23.76%) | -9.68M (+25.88%) | -7.69M (-11.00%) | -8.64M (-17.64%) | -10.49M (+38.21%) | -7.59M (+6.15%) | -7.15M (-19.75%) | -8.91M (+8.53%) | -8.21M (+4.72%) | -7.84M (+10.58%) | -7.09M (-23.43%) | -9.26M (-19.06%) | -11.44M (+26.41%) | -9.05M (-1.52%) | -9.19M (-1.61%) | -9.34M (-21.25%) | -11.86M (+77.81%) | -6.67M (+46.59%) | -4.55M (-10.26%) | -5.07M (-46.86%) | -9.54M (+94.30%) | -4.91M |
Other Income / Expenses | |||||||||||||||||||||||
Interest Income | 1.03M (+1.98%) | 1.01M (-12.17%) | 1.15M (-14.18%) | 1.34M (-4.96%) | 1.41M (-5.37%) | 1.49M (-9.15%) | 1.64M (-1.80%) | 1.67M (+3.73%) | 1.61M (+38.79%) | 1.16M (+4.50%) | 1.11M (+46.05%) | 760K (+80.95%) | 420K (-12.50%) | 480K (+585.71%) | 70K (-12.50%) | 80K (0.00%) | 80K (+100.00%) | 40K (0.00%) | 40K (-50.00%) | 80K (-52.94%) | 170K (-19.05%) | 210K (+110.00%) | 100K |
Net Interest Income | 1.03M (+1.98%) | 1.01M (-12.17%) | 1.15M (-14.18%) | 1.34M (-4.96%) | 1.41M (-5.37%) | 1.49M (-9.15%) | 1.64M (-1.80%) | 1.67M (+3.73%) | 1.61M (+38.79%) | 1.16M (+4.50%) | 1.11M (+46.05%) | 760K (+80.95%) | 420K (-12.50%) | 480K (+500.00%) | 80K (0.00%) | 80K (0.00%) | 80K (+100.00%) | 40K (0.00%) | 40K (-50.00%) | 80K (-52.94%) | 170K (-19.05%) | 210K (+110.00%) | 100K |
Other Non Operating Income | -140.00K | - | 10K | - | - | 10K | -10.00K | - | - | - | 10K | -30.00K | - | 130K | -90.00K | 580K (+9.43%) | 530K | -1.12M | 100K | -90.00K (+200.00%) | -30.00K | 10K | -50.00K |
Net Income | |||||||||||||||||||||||
Income Before Tax | -4.00M (-37.21%) | -6.37M (-25.32%) | -8.53M (+34.12%) | -6.36M (-12.03%) | -7.23M (-19.58%) | -8.99M (+50.84%) | -5.96M (+8.76%) | -5.48M (-24.93%) | -7.30M (+3.40%) | -7.06M (+4.75%) | -6.74M (+5.48%) | -6.39M (-27.96%) | -8.87M (-18.25%) | -10.85M (+19.23%) | -9.10M (+6.31%) | -8.56M (-2.17%) | -8.75M (-32.54%) | -12.97M (+97.71%) | -6.56M (+43.54%) | -4.57M (-7.11%) | -4.92M (-47.38%) | -9.35M (+91.21%) | -4.89M |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | -70.00K (+40.00%) | -50.00K | - | - | - | - | - | -40.00K (+300.00%) | -10.00K | - | - | -280.00K |
Net Income From Continuing Operations | -4.00M (-37.21%) | -6.37M (-25.32%) | -8.53M (+34.12%) | -6.36M (-12.03%) | -7.23M (-19.58%) | -8.99M (+50.84%) | -5.96M (+8.76%) | -5.48M (-24.93%) | -7.30M (+3.40%) | -7.06M (+4.75%) | -6.74M (+6.65%) | -6.32M (-28.43%) | -8.83M (-18.62%) | -10.85M (+19.23%) | -9.10M (+6.31%) | -8.56M (-2.17%) | -8.75M (-32.54%) | -12.97M (+98.62%) | -6.53M (+43.52%) | -4.55M (-7.52%) | -4.92M (-47.38%) | -9.35M (+102.82%) | -4.61M |
Net Income | -4.00M (-37.21%) | -6.37M (-25.32%) | -8.53M (+34.12%) | -6.36M (-12.03%) | -7.23M (-19.58%) | -8.99M (+50.84%) | -5.96M (+8.76%) | -5.48M (-24.93%) | -7.30M (+3.40%) | -7.06M (+4.75%) | -6.74M (+6.65%) | -6.32M (-28.43%) | -8.83M (-18.62%) | -10.85M (+19.23%) | -9.10M (+6.31%) | -8.56M (-2.17%) | -8.75M (-32.54%) | -12.97M (+98.62%) | -6.53M (+43.52%) | -4.55M (-7.52%) | -4.92M (-47.38%) | -9.35M (+102.82%) | -4.61M |